Cancers of unknown primary origin: current perspectives and future therapeutic strategies

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1479-5876

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Cancers of unknown primary origin: current perspectives and future therapeutic strategies ; volume:10 ; number:1 ; day:24 ; month:1 ; year:2012 ; pages:1-11 ; date:12.2012
Journal of translational medicine ; 10, Heft 1 (24.1.2012), 1-11, 12.2012

Creator: Stella, Giulia Maria

Contributor: Senetta, Rebecca
Cassenti, Adele
Ronco, Margherita
Cassoni, Paola
SpringerLink (Online service)

DOI: 10.1186/1479-5876-10-12

URN: urn:nbn:de:1111-2016041440842

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:46 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Stella, Giulia Maria
Senetta, Rebecca
Cassenti, Adele
Ronco, Margherita
Cassoni, Paola
SpringerLink (Online service)

Other Objects (12)

Prediction of tumor origin in cancers of unknown primary origin with cytology-based deep learning

Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin

A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary

Fever of unknown origin (FUO) revised

Human brucellosis and fever of unknown origin

Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)

Emerging therapeutic agents for genitourinary cancers

Neonatal jitteriness of unknown origin and circulating catecholamines

Correction: Human brucellosis and fever of unknown origin

Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin

Correction to: Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)

Hochschulschrift

Specific delivery of therapeutic agents against cancers

Prediction of tumor origin in cancers of unknown primary origin with cytology-based deep learning

Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin

A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary

Fever of unknown origin (FUO) revised

Human brucellosis and fever of unknown origin

Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)

Emerging therapeutic agents for genitourinary cancers

Neonatal jitteriness of unknown origin and circulating catecholamines

Correction: Human brucellosis and fever of unknown origin

Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin

Correction to: Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)

Hochschulschrift

Specific delivery of therapeutic agents against cancers

Prediction of tumor origin in cancers of unknown primary origin with cytology-based deep learning

Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin

A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary

Fever of unknown origin (FUO) revised

Human brucellosis and fever of unknown origin

Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)

Emerging therapeutic agents for genitourinary cancers

Neonatal jitteriness of unknown origin and circulating catecholamines

Correction: Human brucellosis and fever of unknown origin

Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin

Correction to: Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)

Hochschulschrift

Specific delivery of therapeutic agents against cancers

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Cancers of unknown primary origin: current perspectives and future therapeutic strategies

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Prediction of tumor origin in cancers of unknown primary origin with cytology-based deep learning

Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin

A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary

Fever of unknown origin (FUO) revised

Human brucellosis and fever of unknown origin

Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)

Emerging therapeutic agents for genitourinary cancers

Neonatal jitteriness of unknown origin and circulating catecholamines

Correction: Human brucellosis and fever of unknown origin

Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin

Correction to: Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)

Specific delivery of therapeutic agents against cancers

Prediction of tumor origin in cancers of unknown primary origin with cytology-based deep learning

Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin

A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary

Fever of unknown origin (FUO) revised

Human brucellosis and fever of unknown origin

Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)

Emerging therapeutic agents for genitourinary cancers

Neonatal jitteriness of unknown origin and circulating catecholamines

Correction: Human brucellosis and fever of unknown origin

Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin

Correction to: Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)

Specific delivery of therapeutic agents against cancers

Prediction of tumor origin in cancers of unknown primary origin with cytology-based deep learning

Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin

A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary

Fever of unknown origin (FUO) revised

Human brucellosis and fever of unknown origin

Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)

Emerging therapeutic agents for genitourinary cancers

Neonatal jitteriness of unknown origin and circulating catecholamines

Correction: Human brucellosis and fever of unknown origin

Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin

Correction to: Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)

Specific delivery of therapeutic agents against cancers

Related objects

Reset password